Exogenous thrombospondin stimulates the proliferation of non-thrombospondin-producing cells

International Journal of Oncology

Volumn 13, Issue 2, 1998, Pages 355-359

  Yamashita, Yuichi ^a   Sendo, Seiichi ^b   Hosokawa, Tetsuya ^b   Tuszynski, George ^c   Kurohiji, Toshihiko ^b   Beppu, Richiko ^a   Shinohara, Tetsuo ^a   Kinugasa, Tetsushi ^a   Shirakusa, Takayuki ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Koga Hospital   (Japan)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Proliferation; Receptor; Thrombospondin

Indexed keywords

RECEPTOR ANTIBODY; THROMBOSPONDIN;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

ANTIGENS, CD36; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; COLONIC NEOPLASMS; HUMANS; LIGHT; LIVER NEOPLASMS; MICROSCOPY; MICROSCOPY, IMMUNOELECTRON; STIMULATION, CHEMICAL; THROMBOSPONDINS; TUMOR CELLS, CULTURED;

EID: 0031819684     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.2.355     Document Type: Article

References (41)

1. Tuszynski GP, Srivastava S, Switalska HI, Holt JC, Cierniewski CS and Niewiarowski S: The interaction of human thrombospondin with fibrinogen. J Biol Chem 260: 12240-12245, 1985.
2. Mosher DF, Doyle MJ and Jaffe EA: Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol 93: 343-348, 1982.
3. Raugi GJ, Mumby SM, Abbott-Brown D and Bornstein P: Thrombospondin: synthesis and secretion by cells in culture. J Cell Biol 95: 351-354, 1982.
4. Jaffe EA, Ruggiero JT, Leung LK, Doyle MJ, McKeown-Longo PJ and Mosher DF: Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 80: 998-1002, 1983.
5. Sage H, Farm FM, Striker GE and Fisher AB: Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry 22: 2148-2155, 1983.
6. Jaffe EA, Ruggiero JT and Falcone DJ: Monocytcs and macrophages synthesize and secrete thrombospondin. Blood 65: 79-84, 1985.
7. Mosher DF: Physiology of thrombospondin. Ann Rev Med 41: 85-97, 1990.
8. Riser BL, Varani J, O'Rourke K and Dixit VM: Thrombospondin binding by human squamous carcinoma and melanoma cells: relationship to biological activity. Exp Cell Res 174: 319-329, 1988.
9. Varani J, Riser BL, Hughes LA, Carey TE, Fliegel SEG and Dixit VM: Characterization of thrombospondin synthesis, secretion and cell surface expression by human cells. Clin Exp Metastasis 7: 265-276, 1989.
10. Wright TN, Raugi GJ, Mumby SM and Bornstein P: Light microscopic immunolocalization of thrombospondin in human tissues. J Histochem Cytochem 33: 295-302, 1985.
11. Tuszynski GP, Rothman VL, Murphy A, Siegler K, Smith L, Smith S, Karczewski J, et al: Thrombospondin promotes cell-substratum adhesion. Science 236: 1570-1573, 1987.
12. Gasic GJ, Tuszynski GP and Gorelik E: Interactions of the hemostatic and immune systems in the metastatic spread of tumor cells. Int Rev Exp Pathol 29: 173-212, 1986.
13. Murphy-Ullrich JE and Hook M: Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol 109: 1309-1319, 1989.
14. Taraboletti G, Roberts D, Liotta LA and Giavazzi R: Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 111: 765-772, 1990.
15. Nicosia RF and Tuszynski GP: Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol 124: 183-193, 1994.
16. Hosokawa T, Akihiko M, Rothman VL, Paple M and Tuszynski GP: The effect of thrombospondin on the invasion into fibrin gels by human A549 lung carcinoma. Oncol Res 5: 183-189, 1993.
17. Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA and Gasic GJ: Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res 47: 4130-4133, 1987.
18. Tuszynski GP, Rothman VL, Deutch AH, Hamilton BK and Eyal J: Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin and malarial proteins. J Cell Biol 116: 209-217, 1992.
19. Tuszynski GP, Rothman VL, Papale M, Hamilton BK and Eyal J: Identification of a tumor cell receptor for CSVTCG: a thrombospondin adhesive domain. J Cell Biol 120: 513-521, 1993.
20. Tuszynski GP and Nicosia RF: Localization of thrombospondin and its cysteine-serine-valine-theonine-cysteine-glycine-specific receptor in human breast carcinoma. Lab Invest 70: 228-233, 1994.
21. Murakami T: Establishment and characterization of human hepatoma cell line (KIM-1). Acta Hepatol Jpn 25: 532-539, 1984.
22. Takata M: The tumoricidal efficacy of povidone-iodine for exfoliated colorectal carcinoma cells in the fresh operative specimen. Jpn J Gastroenterol Surg 30: 1739-1746, 1997.
23. Baenziger NL, Brodie GN and Majerus PW: A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 68: 240-243, 1971.
24. Baenziger NL, Brodie GN and Majerus PW: Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem 247: 2723-2731, 1972.
25. Gartner TK, Gerrard JM, White JG and Williams DC: Fibrinogen is the receptor for the endogenous lectin of human platelets. Nature 289: 688-690, 1981.
26. Jaffe EA, Leung L-K, Nachman RL, Levin RI and Mosher DF: Thrombospondin is the endogenous lectin of human platelets. Nature 295: 246-248, 1982.
27. Wolff R, Plow EF and Ginsberg MH: Interaction of thrombospondin with resting and stimulated human platelets. J Biol Chem 261: 6840-6846, 1986.
28. Taraboletti G, Roberts D and Liotta LA: Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 105: 2409-2415, 1987.
29. Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA and Gasic GJ: Thrombospondin: a potentiator of tumor cell metastasis. Cancer Res 47: 4130-4133, 1987.
30. Hosokawa T, Muraishi A, Rothman VL, Papale M and Tuszynski GP: The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma. Oncol Res 5: 183-189, 1993.
31. Incardona F, Lewalle JM, Morandi V, Lambert S, Legrand Y, Foidart JM and Legrand C: Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Cancer Res 55: 166-173, 1995.
32. Pratt DA, Miller WR and Dawes J: Thrombospondin in malignant and non-malignant breast tissue. Eur J Cancer Clin Oncol 25: 343-350, 1989.
33. Wong S-Y, Purdie AT and Han P: Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am J Pathol 140: 1473-1482, 1992.
34. Clezardin P, Frappart L, Clerget M, Pechoux C and Delmas PD: Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res 53: 1421-1430, 1993.
35. Yabkowitz R, Mansfield PJ, Dixit VM and Suchard SJ: Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains. Cancer Res 53: 378-387, 1993.
36. Hayashi K, Kurohiji T and Shirouzu K: Localization of thrombospondin in hepatocellular carcinoma. Hepatology 25: 569-574, 1997.
37. Nagata S, Kurohiji T and Shirouzu K: The effect of thrombospondin on hepatocellular carcinoma cell proliferation. Int J Oncol 11: 1373-1378, 1997.
38. Zabrenetzky VS, Harris CC, Steeg PS and Roberts DD: Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 59: 191-195, 1994.
39. Chaudhury RA, Frazier WA and d'Amore PA: Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-beta. J Cell Sci 107: 39-46, 1994.
40. Weinstat-Saslow DL, Zabrenetzky VS, vanHoutte K, Frazier WA, Robberts DD and Steeg PS: Transfection of thrombospondin complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54: 6504-6511, 1994.
41. Dameron KM, Valpert OV, Tainsky MA and Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584, 1994.